Opportunities and benefits as determinants of the direction of scientific research

Journal of Health Economics

Volumn 30, Issue 4, 2011, Pages 603-615

  Bhattacharya, Jay ^a   Packalen, Mikko ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Induced innovation; Non profit incentives; Research opportunity; Scientific research; Textual econometrics

Indexed keywords

INNOVATION; MEDICINE; PRIVATE SECTOR; RESEARCH;

ARTICLE; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HUMAN; MEDICAL INFORMATION; MEDICAL RESEARCH; PREVALENCE; PRODUCTIVITY; PUBLICATION; RESOURCE ALLOCATION; STATISTICAL ANALYSIS;

BIOMEDICAL RESEARCH; HUMANS; ORGANIZATIONAL INNOVATION; PREVALENCE; PRIVATE SECTOR; PUBLIC HEALTH;

EID: 79960926266     PISSN: 01676296     EISSN: 18791646     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2011.05.007     Document Type: Article

References (37)

1. Acemoglu D., Linn J. Market size in innovation: theory and evidence from the pharmaceutical industry. Quarterly Journal of Economics 2004, 119:1049-1090.
2. Adams J.D., Clemons J.R. The NBER-Rensselaer Polytechnic Institute Scientific Papers Database: Characteristics and Purpose 2006, Mimeo.
3. Adams, J.D., Clemons, J.R., 2008. The Origins of Industrial Scientific Discoveries, NBER working paper No. 13823.
4. Aghion P., Dewatripont M., Stein J.C. Academic freedom, private-sector focus, and the process of innovation. RAND Journal of Economics 2008, 39:617-635.
5. Azoulay P., Ding W., Stuart T. The determinants of faculty patenting behavior: demographics or opportunities?. Journal of Economic Behavior & Organization 2007, 63:599-623.
6. Azoulay P., Ding W., Stuart T. The effect of academic patenting on the rate, quality, and direction of (public) research output. Journal of Industrial Economics 2009, 57:637-676.
7. Azoulay P., Michigan R., Sampat B.N. The anatomy of medical school patenting. The New England Journal of Medicine 2007, 357:2049-2056.
8. Bhattacharya, J., Packalen, M., 2008a. Is Medicine an Ivory Tower? Induced Innovation, Technological Opportunity, and For-Profit vs. Non-Profit Innovation, NBER working paper No. 13862.
9. Bhattacharya, J., Packalen, M., 2008b. The Other Ex-Ante Moral Hazard in Health, NBER working paper No. 13863.
10. Caballero R.J., Jaffe A.B. How high are the giants' shoulders: an empirical assessment of knowledge spillovers and creative destruction in a model of economic growth. NBER Macroeconomics Annual 1993 1993, 15-74. MIT Press, Cambridge. O.J. Blanchard, S. Fisher (Eds.).
11. Cameron, A.C., Gelbach, J.B., Miller, D.L., 2008. Bootstrap-based improvements for inference with clustered errors. Review of Economics and Statistics 90, 414-427.
12. Cockburn I.M., Henderson R.M. Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery. The Journal of Industrial Economics 1998, 46:157-182.
13. Dasgupta P., David P.A. Towards a new economics of science. Research Policy 1994, 23:487-521.
14. DellaVigna S., Pollet J.M. Demographics and industry returns. American Economic Review 2007, 97:1667-1702.
15. Finkelstein A. Static and dynamic effects of health policy: evidence from the vaccine industry. Quarterly Journal of Economics 2004, 119:527-564.
16. George L., Waldfogel J. Who affects whom in daily newspaper markets?. Journal of Political Economy 2003, 111:765-784.
17. The Governance of Not-for-Profit Organizations 2003, The University of Chicago Press, Chicago. E.L. Glaeser (Ed.).
18. Jaffe A.B., Trajtenberg M. Flows of knowledge from universities and federal labs: modeling the flow of patent citations over time and across institutional and geographic boundaries. Proceedings of the National Academy of Sciences 1996, 93:12671-12677.
19. Hicks J.R. Theory of Wages 1932, Macmillan, London.
20. Lakdawalla D., Philipson T. The nonprofit sector and industry performance. Journal of Public Economics 2006, 90:1681-1698.
21. Lichtenberg F.R. The Allocation of Publicly Funded Biomedical Research. Medical Care Output and Productivity: Studies in Income and Wealth, vol. LXIII 1999, University of Chicago Press, Chicago. E. Berndt, D. Cutler (Eds.).
22. Lichtenberg, F.R., 2006. Importation and Innovation, NBER working paper No. 12539.
23. Lichtenberg, F.R., Waldfogel, J., 2003. Does Misery Love Company? Evidence from Pharmaceutical Markets Before and After the Orphan Drug Act, NBER working paper No. 9750.
24. Mane K.K., Börner K. Mapping topics and topic bursts in PNAS. Proceedings of the National Academy of Sciences 2004, 101:5287-5290.
25. Merton, R.K., 1973 [1942]. The normative structure of science. In: Merton, R.K. (Ed.), The Sociology of Science: Theoretical and Empirical Investigations. The University of Chicago Press, Chicago.
26. Michel, J.-B., Shen, Y.-K., Aiden, A.P., Veres, A., Gray, M.K., The Google Books Team, Pickett, J.P., Hoiberg, D., Clancy, D., Norvig, P., Orwant, J., Pinker, S., Nowak, M.A., Aiden, E.L., 2011. Quantitative Analysis of Culture Using Millions of Digitized Books, Science, 14 January, pp. 176-182.
27. Murray F., Stern S. Do formal intellectual property rights hinder the free flow of scientific knowledge? An empirical test of the anti-commons hypothesis. Journal of Economic Behavior and Organizations 2007, 63:648-687.
28. Newell R.A., Jaffee A., Stavins R. The induced innovation hypothesis and energy-saving technological change. Quarterly Journal of Economics 1999, 114:907-940.
29. Popp D. Induced innovation and energy prices. American Economic Review 2002, 92:160-180.
30. Rosenberg N. Inside the Black Box: Technology and Economics 1982, Cambridge University Press, Cambridge.
31. Saha, S.B, Weinberg, B., 2008. The Economics of Ivory Towers. Mimeo.
32. Scherer F.M. Firm size market structure opportunity and the output of patented inventions. American Economic Review 1965, 55:1097-1125.
33. Schmookler J. Invention and Economic Growth 1966, Harvard University Press, Cambridge.
34. Stern S. Do scientists pay to be scientists?. Management Science 2004, 50:835-853.
35. Waldfogel J. Preference externalities: an empirical study of who benefits whom in differentiated product markets. RAND Journal of Economics 2003, 34:557-568.
36. Ward M.R., Dranove D. The vertical chain of research and development in the pharmaceutical industry. Economic Inquiry 1995, 33:70-87.
37. Yin W. Market incentives and pharmaceutical innovation. Journal of Health Economics 2008, 27:1060-1077.